4//SEC Filing
Actinium Pharmaceuticals, Inc. 4
Accession 0001213900-17-002450
$ATNMCIK 0001388320operating
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:07 PM ET
Size
5.5 KB
Accession
0001213900-17-002450
Insider Transaction Report
Form 4
CICIC DRAGAN
COO and CMO
Transactions
- Award
Options to purchase common stock
2017-03-14$1.39/sh+75,000$104,250→ 75,000 totalExercise: $1.39Exp: 2027-03-14→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant.
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001388320
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:07 PM ET
- Size
- 5.5 KB